Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (171-180 of 492) with videos related to

Pageof 50
Sort By:
Plos One|February 25, 2022
Low-grade proteinuria and atherosclerotic cardiovascular disease: A transition study of patients with diabetic kidney diseaseSatoshi Yamaguchi, Takayuki Hamano, Tatsufumi Oka, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|June 16, 2023
Resurgence of human coronavirus OC43 at a long-term care facility during the coronavirus disease 2019 (COVID-19) pandemic: Outbreak investigationKoji Ohyama, Hitoshi Honda, Momoko Aoki, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 19, 2021
Association of Time-Updated Anion Gap With Risk of Kidney Failure in Advanced CKD: A Cohort StudyYuta Asahina, Yusuke Sakaguchi, Sachio Kajimoto, et al.
Hypertension (Dallas, Tex. : 1979)|January 14, 2022
Mineralocorticoid Receptor Antagonist Use and Hard Renal Outcomes in Real-World Patients With Chronic Kidney DiseaseTatsufumi Oka, Yusuke Sakaguchi, Koki Hattori, et al.
Diagnostic Microbiology and Infectious Disease|March 26, 2019
Antimicrobial treatment challenges in the era of carbapenem resistanceAnna Maria Peri, Yohei Doi, Brian A Potoski, et al.
Jac-Antimicrobial Resistance|June 30, 2025
Comparative <i>in vitro</i> activity of sulbactam with avibactam or durlobactam against carbapenem-resistant <i>Acinetobacter baumannii</i>Ava J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Journal of Nephrology|January 16, 2022
Intradialytic hypotension and objectively measured physical activity among patients on hemodialysisKoki Hattori, Yusuke Sakaguchi, Sachio Kajimoto, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|May 30, 2009
Structure of AmpC beta-lactamase (AmpCD) from an Escherichia coli clinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helixYoshihiro Yamaguchi, Genta Sato, Yuriko Yamagata, et al.
Clinical Kidney Journal|May 2, 2022
Time-updated anion gap and cardiovascular events in advanced chronic kidney disease: a cohort studyYuta Asahina, Yusuke Sakaguchi, Sachio Kajimoto, et al.
Emerging Infectious Diseases|October 22, 2015
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USAHind Alrowais, Christi L McElheny, Caressa N Spychala, et al.
Pageof 50

Showing results (171-180 of 492) with videos related to

Sort By:
Pageof 50
Plos One|February 25, 2022
Low-grade proteinuria and atherosclerotic cardiovascular disease: A transition study of patients with diabetic kidney diseaseSatoshi Yamaguchi, Takayuki Hamano, Tatsufumi Oka, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|June 16, 2023
Resurgence of human coronavirus OC43 at a long-term care facility during the coronavirus disease 2019 (COVID-19) pandemic: Outbreak investigationKoji Ohyama, Hitoshi Honda, Momoko Aoki, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 19, 2021
Association of Time-Updated Anion Gap With Risk of Kidney Failure in Advanced CKD: A Cohort StudyYuta Asahina, Yusuke Sakaguchi, Sachio Kajimoto, et al.
Hypertension (Dallas, Tex. : 1979)|January 14, 2022
Mineralocorticoid Receptor Antagonist Use and Hard Renal Outcomes in Real-World Patients With Chronic Kidney DiseaseTatsufumi Oka, Yusuke Sakaguchi, Koki Hattori, et al.
Diagnostic Microbiology and Infectious Disease|March 26, 2019
Antimicrobial treatment challenges in the era of carbapenem resistanceAnna Maria Peri, Yohei Doi, Brian A Potoski, et al.
Jac-Antimicrobial Resistance|June 30, 2025
Comparative <i>in vitro</i> activity of sulbactam with avibactam or durlobactam against carbapenem-resistant <i>Acinetobacter baumannii</i>Ava J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Journal of Nephrology|January 16, 2022
Intradialytic hypotension and objectively measured physical activity among patients on hemodialysisKoki Hattori, Yusuke Sakaguchi, Sachio Kajimoto, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|May 30, 2009
Structure of AmpC beta-lactamase (AmpCD) from an Escherichia coli clinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helixYoshihiro Yamaguchi, Genta Sato, Yuriko Yamagata, et al.
Clinical Kidney Journal|May 2, 2022
Time-updated anion gap and cardiovascular events in advanced chronic kidney disease: a cohort studyYuta Asahina, Yusuke Sakaguchi, Sachio Kajimoto, et al.
Emerging Infectious Diseases|October 22, 2015
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USAHind Alrowais, Christi L McElheny, Caressa N Spychala, et al.
Pageof 50